Drug recall · January 22, 2014
RIVAROXABAN Tablet recall
Why: Labeling: Label Mixup; RIVAROXABAN Tablet, 20 mg may be potentially mislabeled as VENLAFAXINE HCL, Tablet, 100 mg, NDC 00093738301, Pedigree: W002619, EXP: 6/4/2014.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
RIVAROXABAN Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 50458057930
- Lots / codes
RIVAROXABAN, Tablet, 20 mg has the following code Pedigree: W002620, EXP: 6/4/2014.
- Quantity
- 30 Tablets
- Company
- Aidapak Services, LLC, Vancouver, WA
- Distribution
- Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
- Initiated
- July 2, 2013 · Voluntary: Firm initiated
- Classified
- January 16, 2014
- Reported
- January 22, 2014
- Ended
- February 7, 2014
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Rivaroxaban
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.